A strong and responsive Administrative Core is a key component of the Boston University Alzheimer's Disease Center (BU ADC). The Administrative Core consists of a formal administrative structure under the leadership of the BU ADC Director, Dr Kowall. Three standing administrative committees have been established: the Executive Committee, the External Advisory Committee, and the Community Action Council and an ad hoc Internal Advisory Committee. In conjunction with the Center Director, these committees are responsible for coordinating, planning, overseeing, and evaluating all BU ADC activities and ensuring the optimal utilization of BU ADC resources. The budget for the Administrative Core supports centralized administrative personnel and activities relevant to the overall mission of the BU ADC. The budgets for other administrative functions assigned to specific cores are included in individual core budgets.
The aims of the BU ADC administrative core are: 1. To integrate, coordinate, direct and plan all BUADC activities and to ensure full compliance with all human subjects, animal welfare, scientific integrity, and financial policy requirements of NIH while promoting a culture that values and promotes the highest standards of ethics in clinical care and research guided by input from the scientific and lay communities. 2. To foster innovative AD research through a strong pilot project program, by facilitating cross-core interactions, and by maximizing resource utilization to support affiliated programs such as the Framingham Heart Study and the Center for the Study of Traumatic Encephalopathy. 3. To partner with the local, regional, national and international AD research community to support high impact research including the Framingham Heart Study, ADNI, ADCS, AD genetics consortium, and industry sponsored clinical trials. To ensure that all mandated data sets, such as the UDS, are submitted to NACC in an accurate and timely manner. 4. To support and inform the communities we serve regarding the benefits of the BU ADC and AD research. We have an active and engaged Community Action Council, have a longstanding and strong affiliation with the Massachusetts Alzheimer Association, and actively partner with Continuing Care Retirement Communities in the greater Boston area.

Public Health Relevance

The Administrative Core serves as the interface between internal BU ADC activities and external entities and ensures that internal BU ADC operations are optimally managed. It makes certain that BU ADC activities are consistent with the mission of the national NIA ADC program and that it is doing its best to meet the needs of the AD community.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG013846-19
Application #
8690706
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
19
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Boston University
Department
Type
DUNS #
City
Boston
State
MA
Country
United States
Zip Code
02118
Brent, Robert J (2018) Estimating the monetary benefits of medicare eligibility for reducing the symptoms of dementia. Appl Econ 50:6327-6340
Deming, Yuetiva; Dumitrescu, Logan; Barnes, Lisa L et al. (2018) Sex-specific genetic predictors of Alzheimer's disease biomarkers. Acta Neuropathol 136:857-872
Li, Dan; Wang, Lei; Maziuk, Brandon F et al. (2018) Directed evolution of a picomolar-affinity, high-specificity antibody targeting phosphorylated tau. J Biol Chem 293:12081-12094
Tagge, Chad A; Fisher, Andrew M; Minaeva, Olga V et al. (2018) Concussion, microvascular injury, and early tauopathy in young athletes after impact head injury and an impact concussion mouse model. Brain 141:422-458
Crum, Jana; Wilson, Jeffrey; Sabbagh, Marwan (2018) Does taking statins affect the pathological burden in autopsy-confirmed Alzheimer's dementia? Alzheimers Res Ther 10:104
Tse, Kai-Hei; Cheng, Aifang; Ma, Fulin et al. (2018) DNA damage-associated oligodendrocyte degeneration precedes amyloid pathology and contributes to Alzheimer's disease and dementia. Alzheimers Dement 14:664-679
Petyuk, Vladislav A; Chang, Rui; Ramirez-Restrepo, Manuel et al. (2018) The human brainome: network analysis identifies HSPA2 as a novel Alzheimer’s disease target. Brain 141:2721-2739
Chung, Jaeyoon; Wang, Xulong; Maruyama, Toru et al. (2018) Genome-wide association study of Alzheimer's disease endophenotypes at prediagnosis stages. Alzheimers Dement 14:623-633
Burke, Shanna L; Cadet, Tamara; Maddux, Marlaina (2018) Chronic Health Illnesses as Predictors of Mild Cognitive Impairment Among African American Older Adults. J Natl Med Assoc 110:314-325
Schaffert, Jeff; LoBue, Christian; White, Charles L et al. (2018) Traumatic brain injury history is associated with an earlier age of dementia onset in autopsy-confirmed Alzheimer's disease. Neuropsychology 32:410-416

Showing the most recent 10 out of 791 publications